Diagnos Laboratorium Utama Tbk. vs Puradelta Lestari Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Puradelta Lestari Tbk. trades at Rp137 (market cap 6.6T, 40.24M 24h volume). The key difference: Puradelta Lestari Tbk. is far larger — about 21.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Puradelta Lestari Tbk. is more actively traded (40.24M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | DMAS | |
|---|---|---|
Market Cap | 310.75B | 6.6T |
Volume | 963.6K | 40.24M |
Lot | 9.64K | 402.39K |
Turnover | 217.67M | 5.52B |
Average Price | 225.89 | 137.3 |
Value | 217.67M | 5.52B |
Indicative Equilibrium Price | 226 | 137 |
Indicative Equilibrium Volume | 1K | 9.27K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Puradelta Lestari Tbk (the Company) was established in Republic of Indonesia based on Notarial Deed of Ano Muhamad Nasruddin No. 77 dated November 12, 1993, a substitute notary of Koswara, S.H., a public notary in Bandung. The Company has changed its status into Foreign Capital Investment (PMA) based on Notarial Deed No. 67 dated October 5, 1996 of Adam Kasdarmadji, S.H., a publicnotary in Jakarta.
Read more on DMAS →